Summary:
Do you have a fatty liver? Maybe it’s time to consider a different path.
If you have been told that you have or may have either NASH or a fatty liver, and diet and exercise haven’t worked, you may want to consider participation in a clinical research study at ClinSearch.
The purpose of this study is to evaluate whether an oral investigational medication called volixibat is tolerable, safe, and e ective in treating NASH.
Qualified Participants Must:
• Be between 18 and 80 years of age
•
Not have other liver disease, such as hepatitis B or C
•
Not have cirrhosis
•
Not have uncontrolled diabetes
Qualified Participants May Receive:
Study-related medication, study-related medical exams and compensation for time and travel.